Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Pienta

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
In Vivo (Athens, Greece)|May 1, 1994
The epidemiology of prostate cancer: clues for chemopreventionK J Pienta
Seminars in Oncology|October 31, 2001
Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancerK J Pienta
In Vivo (Athens, Greece)|September 1, 1995
Establishment of an immortalized Copenhagen rat prostate epithelial cell lineK Yamazaki, K J Pienta
Comprehensive Therapy|February 1, 1996
The treatment of hormone refractory prostate cancerR Panvichian, K J Pienta
Prostate Cancer and Prostatic Diseases|December 24, 2002
Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireviewC R Cooper, K J Pienta
Journal of the National Cancer Institute|February 5, 1998
Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell lineJ E Lehr, K J Pienta
Seminars in Oncology|November 5, 1997
Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancerK J Pienta, D C Smith
Oncology (Williston Park, N.Y.)|October 18, 2000
Use of bisphosphonates in the treatment of prostate cancerK B Olson, K J Pienta
The Prostate|January 1, 1993
A common set of nuclear matrix proteins in prostate cancer cellsK J Pienta, J E Lehr
Annals of Internal Medicine|May 15, 1993
Risk factors for prostate cancerK J Pienta, P S Esper
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
In Vivo (Athens, Greece)|May 1, 1994
The epidemiology of prostate cancer: clues for chemopreventionK J Pienta
Seminars in Oncology|October 31, 2001
Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancerK J Pienta
In Vivo (Athens, Greece)|September 1, 1995
Establishment of an immortalized Copenhagen rat prostate epithelial cell lineK Yamazaki, K J Pienta
Comprehensive Therapy|February 1, 1996
The treatment of hormone refractory prostate cancerR Panvichian, K J Pienta
Prostate Cancer and Prostatic Diseases|December 24, 2002
Cell adhesion and chemotaxis in prostate cancer metastasis to bone: a minireviewC R Cooper, K J Pienta
Journal of the National Cancer Institute|February 5, 1998
Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell lineJ E Lehr, K J Pienta
Seminars in Oncology|November 5, 1997
Paclitaxel, estramustine, and etoposide in the treatment of hormone-refractory prostate cancerK J Pienta, D C Smith
Oncology (Williston Park, N.Y.)|October 18, 2000
Use of bisphosphonates in the treatment of prostate cancerK B Olson, K J Pienta
The Prostate|January 1, 1993
A common set of nuclear matrix proteins in prostate cancer cellsK J Pienta, J E Lehr
Annals of Internal Medicine|May 15, 1993
Risk factors for prostate cancerK J Pienta, P S Esper
Pageof 15